Congenital Zika syndrome (CZS) is a non-genetic malformation of cortical development caused by intrauterine infection with Zika virus (ZIKV), a mosquito-borne flavivirus. After maternal infection — most consequential for fetal neurodevelopment during the first and second trimesters — ZIKV crosses the placenta and reaches the developing fetal central nervous system, where it is neurotropic for apical and outer radial glia and other neural progenitor cells of the cortical ventricular and subventricular zones. Productive infection of these founder progenitors dysregulates the cell cycle, triggers caspase-mediated apoptosis, and activates innate antiviral signalling (including the TLR3 pathway and type I interferon responses), collectively depleting the progenitor pool and abrogating neurogenesis during the peak neurogenic window. The resulting deficit of cortical neurons produces the recognizable CZS phenotype: severe (often congenital) microcephaly with a markedly disproportionate skull, agyria/lissencephaly-like smooth cortex, intracranial (cortical and subcortical) calcifications, ventriculomegaly/hydrocephalus, and cortical thinning, frequently accompanied by ocular abnormalities, arthrogryposis, sensorineural hearing loss, seizures, and global developmental delay. CZS is the exemplar infectious (non-Mendelian) cortical malformation mechanism: its proximal cause is a defined viral exposure rather than a germline variant, but it converges on the same progenitor-depletion endpoint as genetic primary microcephaly, distinguished pathologically by a more destructive process with prominent cell death, necrosis, and calcification.
Ask a research question about Congenital Zika Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Congenital Zika Syndrome:
name: Congenital Zika Syndrome
creation_date: "2026-06-10T12:00:00Z"
category: Infectious Disease
disease_term:
preferred_term: Zika virus congenital syndrome
term:
id: MONDO:0000890
label: Zika virus congenital syndrome
parents:
- Microcephaly
synonyms:
- CZS
- congenital Zika virus syndrome
- Zika virus congenital syndrome
- congenital Zika virus infection
notes: >-
Two things about this entry are worth knowing before extending it.
First, the risk figures are lower than the outbreak-era coverage implies and
should not be quoted from memory. In the largest Brazilian prospective cohort,
major signs of CZS occurred in 2.5% of fetuses of symptomatic ZIKV-infected
women and microcephaly or other CNS malformation in 3.9% of liveborn infants.
What is large is not the absolute risk but its dependence on timing: fetal
abnormalities were 14 times more likely when maternal infection occurred at or
before 11 weeks.
Second, head circumference is not a sufficient case definition, and the entry
is curated so as not to imply that it is. Ventricular enlargement in CZS can be
obstructive rather than ex-vacuo and present with a LARGE head; eye
abnormalities and neurological alert signs occur in infants who appear normal
at birth; and the reported frequency of sensorineural hearing loss depends
entirely on whether the cohort was ascertained by microcephaly. Each of those
is curated with the evidence that establishes it rather than left as caveat
prose.
description: >-
Congenital Zika syndrome (CZS) is a non-genetic malformation of cortical
development caused by intrauterine infection with Zika virus (ZIKV), a
mosquito-borne flavivirus. After maternal infection — most consequential for
fetal neurodevelopment during the first and second trimesters — ZIKV crosses
the placenta and reaches the developing fetal central nervous system, where it
is neurotropic for apical and outer radial glia and other neural progenitor
cells of the cortical ventricular and subventricular zones. Productive
infection of these founder progenitors dysregulates the cell cycle, triggers
caspase-mediated apoptosis, and activates innate antiviral signalling
(including the TLR3 pathway and type I interferon responses), collectively
depleting the progenitor pool and abrogating neurogenesis during the peak
neurogenic window. The resulting deficit of cortical neurons produces the
recognizable CZS phenotype: severe (often congenital) microcephaly with a
markedly disproportionate skull, agyria/lissencephaly-like smooth cortex, intracranial
(cortical and subcortical) calcifications, ventriculomegaly/hydrocephalus,
and cortical thinning, frequently accompanied by ocular abnormalities,
arthrogryposis, sensorineural hearing loss, seizures, and global
developmental delay. CZS is the exemplar infectious (non-Mendelian) cortical
malformation mechanism: its proximal cause is a defined viral exposure rather
than a germline variant, but it converges on the same progenitor-depletion
endpoint as genetic primary microcephaly, distinguished pathologically by a
more destructive process with prominent cell death, necrosis, and
calcification.
pathophysiology:
- name: Tunneling Nanotube-Mediated Intercellular Viral Spread
biological_scale: CELLULAR
description: >-
ZIKV induces tunneling nanotubes (TNTs) — actin-rich, membrane-bounded
intercellular conduits that carry viral components directly from cell to
cell, bypassing the extracellular space. TNT-forming capacity maps to
residues 40-52 of the viral nonstructural protein NS1: an engineered
TNT-deficient mutant (ZIKVΔTNT) disseminates markedly less to maternal
and fetal tissues than TNT-competent virus across multiple pregnancy models.
Because transfer through a TNT is shielded from the extracellular
compartment, this route also appears to let the virus persist in the face of
a maternal type III interferon (IFN-lambda) response, implicating TNTs in
immune evasion as well as in spread.
biological_processes:
- preferred_term: tunneling nanotube formation
term:
id: GO:0120031
label: plasma membrane bounded cell projection assembly
modifier: INCREASED
- preferred_term: TNT-shielded escape from maternal type III interferon control
term:
id: GO:0042783
label: symbiont-mediated evasion of host immune response
modifier: INCREASED
- preferred_term: maternal type III interferon (IFN-lambda) signaling at the maternal-fetal interface
term:
id: GO:0038196
label: type III interferon-mediated signaling pathway
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We previously showed that ZIKV induces tunneling nanotubes (TNTs), actin-rich intercellular conduits that enable direct cell-to-cell transfer of viral components."
explanation: Defines TNTs as actin-rich conduits mediating direct cell-to-cell transfer of ZIKV components.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "A TNT-deficient ZIKV mutant (ZIKVΔTNT), harboring a change between residues 40 and 52 of the nonstructural protein 1 (NS1), showed markedly reduced viral dissemination to maternal and fetal tissues across all models tested, whereas the TNT-competent ZIKV established a robust infection."
explanation: Loss-of-function genetic evidence that NS1-dependent TNT formation is required for maternal and fetal dissemination.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Loss of TNT-forming capacity also limited viral persistence despite maternal type III interferon (IFN-λ) responses, suggesting a role for TNTs in immune evasion."
explanation: Links TNT-mediated spread to viral persistence under an active maternal IFN-lambda response.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Together, these findings provide in vivo evidence that TNTs are a key mechanism by which ZIKV enhances dissemination, promotes placental dysfunction, and drives fetal pathogenesis."
explanation: The authors' in vivo summary claim placing TNTs upstream of placental dysfunction and fetal pathology.
notes: >-
No ontology term exists for the tunneling nanotube itself in GO, CL, or
UBERON, so the structure is carried as a free-text `preferred_term` over the
closest available parent process rather than being force-bound to `cytoneme`
(GO:0035230) or `intercellular bridge` (GO:0045171), which name different
structures. Recorded as an OBO gap. All evidence for this node is mouse
in vivo; TNTs have not been demonstrated in human placental tissue in vivo
(see the discussions block).
downstream:
- target: Placental Infection
description: >-
TNT-mediated spread within the placenta drives productive placental
infection.
- target: Transplacental Viral Transfer to the Fetal Compartment
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >-
TNT-competent virus reaches maternal and fetal tissues far more
efficiently than TNT-deficient virus. The edge is retained because that
dissemination difference is directly measured, but marked indirect: the
route to the fetal compartment runs through placental infection, which is
curated as its own node between the two.
- name: Placental Infection
biological_scale: TISSUE
description: >-
ZIKV productively infects the placenta, producing histological placental
pathology. The causal role of viral spread is established by the contrast
with the TNT-deficient mutant, which produces less placental pathology. The
placenta is therefore not merely a barrier ZIKV crosses but a target organ
in its own right.
cell_types:
- preferred_term: trophoblast cell
term:
id: CL:0000351
label: trophoblast cell
locations:
- preferred_term: placenta
term:
id: UBERON:0001987
label: placenta
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
explanation: States directly that TNT-competent virus damages the placenta, across the pregnancy models tested.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
explanation: The reduced placental pathology in the TNT-deficient mutant is the loss-of-function counterpart of the damage claim.
notes: >-
The trophoblast cell type is not named in PMID:42627154, whose placental
readouts are the rodent junctional zone and labyrinth; `CL:0000351` is
supplied from general placental biology as the resident parenchymal cell
type of the infected organ, not asserted by this reference. All evidence for
this node is mouse in vivo. No `conforms_to` is declared: the closest
candidate, `innate_antiviral_interferon_response#Viral Interferon Antagonism
and Innate Immune Evasion`, is about pathway antagonism (GO:0039502
symbiont-mediated suppression of interferon signalling), which is a
different mechanism from the physical compartment-shielding curated here —
considered and declined rather than overlooked.
downstream:
- target: Placental Architectural and Functional Disruption
description: >-
Placental infection is followed by change in the relative architecture of
the placental compartments and a fall in placental efficiency.
- target: Transplacental Viral Transfer to the Fetal Compartment
causal_link_type: DIRECT
description: >-
Placental infection and barrier injury permit virus to reach the fetal
compartment and the developing central nervous system.
- name: Placental Architectural and Functional Disruption
biological_scale: TISSUE
description: >-
Infected placentas differ from TNT-deficient-infected controls in the
relative architecture of the placental compartments, and in placental
efficiency (fetal mass supported per unit placental mass), which improves
when viral spread is crippled.
locations:
- preferred_term: placenta
term:
id: UBERON:0001987
label: placenta
biological_processes:
- preferred_term: placental architecture and efficiency
term:
id: GO:0001890
label: placenta development
modifier: ABNORMAL
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
explanation: Reports the altered compartment architecture and the improved placental efficiency of the TNT-deficient condition.
notes: >-
CRITICAL species caveat: the junctional zone and labyrinth are compartments
of the *rodent* placenta and have no direct human homolog, so the measured
"junctional-to-labyrinth architecture" readout cannot be carried over to
human placental pathology. All evidence for this node is mouse in vivo.
Scope of what the source states: the architectural readout is reported as
*altered* in the TNT-deficient condition, with no direction given, so this
node makes no claim about which way TNT-competent infection shifts it. The
efficiency change does have a direction — the mutant improves it — and is
stated as such in the description.
downstream:
- target: Fetal Growth Restriction
description: >-
Reduced placental efficiency limits fetal growth; crippling viral spread
protects against the growth deficit.
- name: Fetal Growth Restriction
biological_scale: ORGANISM
description: >-
The most distal outcome of the placental arm in the pregnancy models tested:
TNT-competent ZIKV infection leads to fetal growth restriction, while
TNT-deficient infection protects against it.
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
explanation: Protection from fetal growth restriction in the TNT-deficient condition is the loss-of-function evidence for this outcome.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
explanation: States that TNT-competent virus leads to fetal growth restriction across the models tested.
notes: >-
Curated as an ORGANISM-scale pathophysiology node carrying MODEL_ORGANISM
evidence, and deliberately NOT added to `phenotypes:` as a human phenotype:
the finding is mouse-only, and model-organism evidence should not be the
sole support for a human phenotype. A human citation would be needed to
promote it. See the discussions block.
- name: Transplacental Viral Transfer to the Fetal Compartment
biological_scale: TISSUE
description: >-
Crossing the maternal-fetal interface is a transport step, distinct from
what the virus does once it arrives. Human placental work identifies more
than one route rather than a single breach: ZIKV productively infects
placental macrophages (Hofbauer cells) and, less efficiently,
cytotrophoblasts in term villous tissue, and separately infects
cytotrophoblasts, endothelial cells, fibroblasts and Hofbauer cells in
chorionic villi together with amniotic epithelial cells and trophoblast
progenitors in amniochorionic membranes. Those cells express the Axl, Tyro3
and TIM1 entry cofactors, so the same TAM-family biology operates here as in
the fetal brain — but on different cells, in a different organ, supporting a
different claim. Curating them as one node conflated the two.
Transfer is not uniformly permissive, and the restriction side explains the
timing dependence the rest of this entry rests on. Primary human trophoblasts
from full-term placentas are refractory to ZIKV and constitutively release
type III interferon (IFN-lambda1) that protects both trophoblast and
non-trophoblast cells, so virus reaching the fetal compartment must evade or
bypass that barrier. Consistent with a barrier that strengthens as gestation
proceeds, mid-gestation amniotic epithelial cells support higher viral titres
than late-gestation cells.
cell_types:
- preferred_term: Hofbauer cell (placental macrophage)
term:
id: CL:3000001
label: Hofbauer cell
- preferred_term: Cytotrophoblast
term:
id: CL:0000523
label: mononuclear cytotrophoblast cell
biological_processes:
- preferred_term: type III interferon production by trophoblast
term:
id: GO:0034343
label: type III interferon production
locations:
- preferred_term: placenta
term:
id: UBERON:0001987
label: placenta
mechanism_confidence: ESTABLISHED
evidence:
- reference: PMID:27247001
reference_title: "Zika Virus Infects Human Placental Macrophages."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Our results suggest a mechanism for intrauterine transmission in which ZIKV gains access to the fetal compartment by directly infecting placental cells and disrupting the placental barrier."
explanation: >-
States the transfer mechanism this node curates, in primary human placental
cells rather than in a model organism.
- reference: PMID:27247001
reference_title: "Zika Virus Infects Human Placental Macrophages."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "infects and replicates in primary human placental macrophages, called Hofbauer cells, and to a lesser extent in cytotrophoblasts, isolated from villous tissue of full-term placentae"
explanation: Identifies the two placental cell types curated on this node, with their relative permissiveness.
- reference: PMID:27443522
reference_title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Our results suggest that ZIKV spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that targeting TIM1 could suppress infection at the uterine-placental interface."
explanation: >-
The two-route structure of transfer, and the cofactor that is druggable at
the uterine-placental interface specifically.
- reference: PMID:27443522
reference_title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "ZIKV produced NS3 and E proteins and generated higher viral titers in amniotic epithelial cells from mid-gestation compared to late-gestation placentas."
explanation: >-
Gestational-age dependence measured at the placenta, which is the
mechanistic counterpart of the clinical first-trimester risk.
- reference: PMID:27066743
reference_title: "Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "PHT cells constitutively release the type III interferon (IFN) IFNλ1, which functions in both a paracrine and autocrine manner to protect trophoblast and non-trophoblast cells from ZIKV infection."
explanation: >-
The restriction arm. Transfer has to defeat a constitutive barrier, which
is why it is inefficient and gestational-age dependent rather than
obligate.
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ZIKV was found in the fetal brain tissue on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, with consistent findings on electron microscopy."
explanation: >-
Human confirmation that the transfer step completes: virus is recovered
from fetal brain after maternal infection.
- reference: PMID:27279226
reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Here we demonstrate that ZIKV(BR) infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice."
explanation: In vivo evidence that transfer occurs and is sufficient to produce fetal disease.
downstream:
- target: Neurotropic Entry into Fetal Neural Progenitors
causal_link_type: DIRECT
description: >-
Virus that has reached the fetal compartment encounters the developing
cortex, where a separate set of receptors and cell types governs entry.
- name: Neurotropic Entry into Fetal Neural Progenitors
biological_scale: CELLULAR
description: >-
Once in the fetal brain, ZIKV is neurotropic for radial glia and neural
progenitor cells. Candidate entry receptors enriched on these cells —
notably the TAM-family receptor tyrosine kinase AXL, which is highly
expressed by human radial glia in the developing cortex — are thought to
mediate or facilitate viral attachment and entry, establishing infection of
the founder progenitor population during corticogenesis. Neuropathology
confirms the target: infection of progenitor cells at the germinal matrix
has been demonstrated in human material.
AXL appears on both sides of this entry's transfer/entry split, and the
duplication is real biology rather than a curation artefact: the same
TAM-family cofactors are used at the placenta and on radial glia. They are
nonetheless different claims about different cells in different organs, and
are curated on the node each belongs to.
conforms_to: viral_neural_progenitor_cytopathy#Fetal Brain Viral Exposure and Progenitor Infection
cell_types:
- preferred_term: Radial glial cell
term:
id: CL:0000681
label: radial glial cell
- preferred_term: Neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
biological_processes:
- preferred_term: Viral entry into host cell
term:
id: GO:0046718
label: symbiont entry into host cell
modifier: INCREASED
- preferred_term: Viral genome replication
term:
id: GO:0019079
label: viral genome replication
modifier: INCREASED
mechanism_confidence: ESTABLISHED
evidence:
- reference: PMID:27038591
reference_title: "Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we found that the candidate viral entry receptor AXL is highly expressed by human radial glial cells, astrocytes, endothelial cells, and microglia in developing human cortex and by progenitor cells in developing retina."
explanation: Identifies AXL on human radial glia as a candidate entry receptor enriched on the progenitor population ZIKV targets.
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Infection of progenitor cells at the germinal matrix was demonstrated."
explanation: >-
Human neuropathological confirmation that the progenitor population is the
infected compartment, rather than this resting on culture systems alone.
downstream:
- target: Antiviral Innate Immune Activation
- target: Viral Mitotic and Centrosome Cytopathy
- target: Spinal Anterior Horn Motor Neuron Loss
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Virus in the developing fetal CNS also reaches the spinal cord, where
anterior horn motor neurons are lost. Whether this reflects the same
progenitor-directed cytopathy operating at a second site, or direct
infection of postmitotic motor neurons, is not established by the
neuropathological material.
- name: Spinal Anterior Horn Motor Neuron Loss
biological_scale: TISSUE
description: >-
Severe motor nerve cell loss in the anterior horn of the spinal cord is a
consistent postmortem finding in congenital ZIKV infection, alongside
hypoplasia of the descending tracts (small basis pontis, pyramids and spinal
corticospinal tracts) that follows the loss of cortical output. The anterior
horn lesion is the one that matters here, because it is what connects this
entry's cortical mechanism to a phenotype the cortex cannot explain.
cell_types:
- preferred_term: Anterior horn motor neuron
term:
id: CL:2000048
label: anterior horn motor neuron
locations:
- preferred_term: ventral horn of spinal cord
term:
id: UBERON:0002257
label: ventral horn of spinal cord
mechanism_confidence: ESTABLISHED
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord."
explanation: >-
The anterior horn lesion, in human postmortem material. Quoted as written,
including the source's duplicated word.
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts."
explanation: >-
The separate, secondary tract hypoplasia that follows cortical loss, kept
distinct from the primary anterior horn lesion above.
downstream:
- target: Fetal Akinesia
causal_link_type: DIRECT
description: >-
Loss of the final common motor pathway removes the fetal movement that
normal joint development depends on.
- name: Fetal Akinesia
biological_scale: ORGANISM
description: >-
Absent or greatly reduced fetal movement, the consequence of losing spinal
motor neurons. This node exists because the resulting arthrogryposis is
neurogenic rather than articular, and the distinction is testable: in the
reported series, high-definition ultrasonography of the joints showed no
abnormality, while needle electromyography showed motor unit remodeling and
reduced recruitment, and spinal MRI showed apparent cord thinning with
reduced ventral roots. The joints are normal; the nerves supplying them are
not.
mechanism_confidence: ESTABLISHED
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis."
explanation: >-
The causal claim this node and its downstream edge encode, stated by the
source. The source's spelling of akinesia is preserved in the quote.
- reference: PMID:27509902
reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities."
explanation: >-
The negative joint imaging that excludes a primary articular cause and so
makes the neurogenic account load-bearing rather than assumed.
- reference: PMID:27509902
reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots."
explanation: >-
Imaging correlate of the anterior horn lesion in living patients, matching
the postmortem finding.
- name: Antiviral Innate Immune Activation
biological_scale: CELLULAR
description: >-
ZIKV infection activates innate antiviral signalling within developing
neural progenitor systems. Human cerebral organoid and neurosphere data
implicate Toll-like receptor 3 (TLR3) activation and type I interferon-linked
responses in perturbed neurogenesis, altered cell fate, and downstream
progenitor loss; TLR3 inhibition mitigates the phenotype in experimental
models.
conforms_to: viral_neural_progenitor_cytopathy#Antiviral Innate Immune Activation
cell_types:
- preferred_term: Neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
- preferred_term: Radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: Innate immune response
term:
id: GO:0045087
label: innate immune response
modifier: INCREASED
- preferred_term: Toll-like receptor signaling pathway
term:
id: GO:0002224
label: toll-like receptor signaling pathway
modifier: INCREASED
- preferred_term: Type I interferon-mediated signaling pathway
term:
id: GO:0060337
label: type I interferon-mediated signaling pathway
modifier: DYSREGULATED
- preferred_term: Defense response to virus
term:
id: GO:0051607
label: defense response to virus
modifier: DYSREGULATED
evidence:
- reference: PMID:27162029
reference_title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The innate immune receptor Toll-like-Receptor 3 (TLR3) was upregulated after ZIKV infection of human organoids and mouse neurospheres and TLR3 inhibition reduced the phenotypic effects of ZIKV infection."
explanation: Implicates TLR3 innate immune activation in ZIKV-driven progenitor cytopathy, with inhibition reducing the experimental phenotype.
- reference: PMID:27162029
reference_title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Together, therefore, our findings identify a link between ZIKV-mediated TLR3 activation, perturbed cell fate, and a reduction in organoid volume reminiscent of microcephaly."
explanation: Connects ZIKV-triggered TLR3 activation to perturbed cell fate and reduced organoid volume in a human cerebral organoid model.
downstream:
- target: Neural Progenitor Apoptosis and Pool Depletion
- name: Viral Mitotic and Centrosome Cytopathy
biological_scale: CELLULAR
description: >-
ZIKV productively infects human neural progenitor cells and radial glia,
releasing infectious virus and perturbing cell-cycle progression, mitotic
machinery, centrosome integrity, and phospho-TBK1 localization. These
mitotic and centrosome defects impair proliferative progenitor divisions and
converge on the same neural progenitor centrosome/spindle dysfunction module
used by genetic cortical malformation entries.
conforms_to: viral_neural_progenitor_cytopathy#Viral Mitotic and Centrosome Cytopathy
cell_types:
- preferred_term: Neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
- preferred_term: Radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: Mitotic cell cycle
term:
id: GO:0000278
label: mitotic cell cycle
modifier: DYSREGULATED
- preferred_term: Cell cycle
term:
id: GO:0007049
label: cell cycle
modifier: DYSREGULATED
- preferred_term: Mitotic spindle organization
term:
id: GO:0007052
label: mitotic spindle organization
modifier: DYSREGULATED
- preferred_term: Centrosome cycle
term:
id: GO:0007098
label: centrosome cycle
modifier: ABNORMAL
evidence:
- reference: PMID:26952870
reference_title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
explanation: Links infection to cell-cycle dysregulation and attenuated progenitor growth.
- reference: PMID:27568284
reference_title: "Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial sequestration of phospho-TBK1 during mitosis."
explanation: Supports mitotic centrosome/TBK1 cytopathy in infected human neuroepithelial stem cells and radial glia.
- reference: PMID:28132835
reference_title: "Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The main phenotypic effect was premature differentiation of neural progenitors associated with centrosome perturbation, even during early stages of infection, leading to progenitor depletion, disruption of the VZ, impaired neurogenesis, and cortical thinning."
explanation: Human brain organoids show ZIKV-associated centrosome perturbation leading to progenitor depletion and cortical thinning.
downstream:
- target: Neural Progenitor Apoptosis and Pool Depletion
- name: Neural Progenitor Apoptosis and Pool Depletion
biological_scale: CELLULAR
description: >-
Innate antiviral activation, viral replication, cell-cycle disruption, and
mitotic/centrosome stress converge on caspase-mediated apoptosis, autophagy,
premature differentiation, and reduced viability of neural progenitors and
radial glia. The founder progenitor pool is depleted, leaving too few
neuron-generating cells for normal cortical expansion.
conforms_to: viral_neural_progenitor_cytopathy#Neural Progenitor Apoptosis and Pool Depletion
cell_types:
- preferred_term: Neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
- preferred_term: Radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: Apoptotic process
term:
id: GO:0006915
label: apoptotic process
modifier: INCREASED
- preferred_term: Neurogenesis
term:
id: GO:0022008
label: neurogenesis
modifier: DECREASED
- preferred_term: Cell population proliferation
term:
id: GO:0008283
label: cell population proliferation
modifier: DECREASED
evidence:
- reference: PMID:27064148
reference_title: "Zika virus impairs growth in human neurospheres and brain organoids."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development."
explanation: Demonstrates that ZIKV reduces human neural progenitor viability/growth and abrogates neurogenesis.
- reference: PMID:26952870
reference_title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
explanation: Connects infection-driven cell death and cell-cycle dysregulation to reduced progenitor growth.
- reference: PMID:27279226
reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKV(BR) crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment."
explanation: Establishes apoptosis and autophagy of cortical progenitors as in vivo mechanisms of ZIKV-induced microcephaly.
downstream:
- target: Impaired Neurogenesis and Congenital Cortical Malformation
- name: Impaired Neurogenesis and Congenital Cortical Malformation
biological_scale: TISSUE
description: >-
Depletion of the cortical progenitor pool and impaired neurogenesis reduce
the complement of cortical neurons, producing severe microcephaly with a
disproportionately small brain. Unlike many genetic microcephalies, the CZS
cortex shows a more destructive pathology, with near-complete agyria
(lissencephaly-like smoothing), multifocal cortical and subcortical
calcifications, hydrocephalus/ventriculomegaly, and cortical displacement,
reflecting prominent cell death during development.
conforms_to: viral_neural_progenitor_cytopathy#Impaired Neurogenesis and Congenital Cortical Malformation
cell_types:
- preferred_term: Neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
biological_processes:
- preferred_term: Neurogenesis
term:
id: GO:0022008
label: neurogenesis
modifier: DECREASED
- preferred_term: Cerebral cortex development
term:
id: GO:0021987
label: cerebral cortex development
modifier: ABNORMAL
evidence:
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
explanation: Human fetal autopsy documenting the destructive cortical malformation phenotype of CZS.
- reference: PMID:27179424
reference_title: "Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKV infection leads to cell-cycle arrest, apoptosis, and inhibition of NPC differentiation, resulting in cortical thinning and microcephaly."
explanation: In vivo recapitulation of cortical thinning and microcephaly as the developmental endpoint.
phenotypes:
- category: Neurologic
name: Microcephaly
diagnostic: true
description: >-
Severe, frequently congenital microcephaly with a markedly disproportionate
skull is the hallmark feature of congenital Zika syndrome.
phenotype_term:
preferred_term: Microcephaly
term:
id: HP:0000252
label: Microcephaly
evidence:
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
explanation: Documents micrencephaly (abnormally small brain) on human fetal autopsy.
- category: Neurologic
name: Lissencephaly
description: >-
Near-complete agyria (a lissencephaly-like smooth cortex) reflects the
severe disruption of cortical development.
phenotype_term:
preferred_term: Lissencephaly
term:
id: HP:0001339
label: Lissencephaly
evidence:
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter"
explanation: Records almost complete agyria (lissencephaly-like) in the affected fetal brain.
- category: Neurologic
name: Intracranial Calcification
frequency: VERY_FREQUENT
description: >-
Multifocal calcifications in the cortex and subcortical white matter are a
characteristic neuroimaging and pathological feature of CZS.
phenotype_term:
preferred_term: Cerebral calcification
term:
id: HP:0002514
label: Cerebral calcification
evidence:
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "multifocal dystrophic calcifications in the cortex and subcortical white matter"
explanation: Documents the characteristic cortical and subcortical calcifications of CZS.
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
explanation: >-
Pooled frequency across 12 Brazilian cohorts, which is the basis for the
VERY_FREQUENT band on this phenotype.
- category: Neurologic
name: Hydrocephalus
description: >-
Hydrocephalus/ventriculomegaly accompanies the cortical malformation in
congenital Zika syndrome.
phenotype_term:
preferred_term: Hydrocephalus
term:
id: HP:0000238
label: Hydrocephalus
evidence:
- reference: PMID:26862926
reference_title: "Zika Virus Associated with Microcephaly."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications"
explanation: Records hydrocephalus in the affected fetal brain.
- category: Musculoskeletal
name: Arthrogryposis
description: >-
Congenital joint contractures, present in the arms and legs of six of seven
children in the defining series and in the legs alone in the seventh, with
bilateral hip dislocation in all seven. Curated as neurogenic: see the
Fetal Akinesia node for the joint-imaging and electromyographic evidence
that separates this from a primary disorder of the joints.
phenotype_term:
preferred_term: Arthrogryposis multiplex congenita
term:
id: HP:0002804
label: Arthrogryposis multiplex congenita
evidence:
- reference: PMID:27509902
reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%)."
explanation: Distribution and frequency of contractures within the series.
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Babies with severe brain lesions are born with arthrogryposis."
explanation: >-
Independent neuropathological confirmation, and the association with lesion
severity.
- category: Auditory
name: Sensorineural Hearing Loss
description: >-
Sensorineural hearing loss in 5 of 70 (7%) infants with microcephaly and
laboratory evidence of ZIKV infection, or 5.8% (4 of 69) after excluding one
child tested following ototoxic antibiotic treatment. All affected infants
had severe microcephaly.
The frequency is ascertainment-dependent and this entry does not generalise
it. A separate cohort of ZIKV-exposed children not selected for microcephaly
found no sensorineural hearing loss over two years. Those results are not in
conflict: they describe different populations, and the contrast is the reason
the recommendation is to test hearing in all exposed infants rather than only
those who look affected.
phenotype_term:
preferred_term: Sensorineural hearing impairment
term:
id: HP:0000407
label: Sensorineural hearing impairment
frequency: OCCASIONAL
evidence:
- reference: PMID:27585248
reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Five (7%) infants had sensorineural hearing loss, all of whom had severe microcephaly"
explanation: >-
The frequency in an infant series ascertained on microcephaly, and the
observation that every affected infant was severely microcephalic.
- reference: PMID:30252119
reference_title: "Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss among Children at 3 and 24 Months Post-Partum."
supports: NO_EVIDENCE
evidence_source: HUMAN_CLINICAL
snippet: "None of the patients evaluated in this study were found to have sensorineural hearing loss."
explanation: >-
Cited to record a negative cohort result, graded NO_EVIDENCE rather than
REFUTE because this cohort was ZIKV-exposed rather than CZS-affected: it
does not bear on whether hearing loss occurs in congenital Zika syndrome,
only on how often it is found when microcephaly is not the entry criterion.
- category: Ophthalmologic
name: Chorioretinal Abnormalities
description: >-
Ocular findings involve both the posterior and anterior segments and are
accompanied by abnormal visual function. They can be the presenting
abnormality, and were found in a small proportion of infants who were
otherwise asymptomatic at birth.
phenotype_term:
preferred_term: Chorioretinal atrophy
term:
id: HP:0000533
label: Chorioretinal atrophy
evidence:
- reference: PMID:33320867
reference_title: "Congenital Zika syndrome: A systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ocular findings in the posterior and anterior segments, abnormal visual function and low birthweight for gestational age"
explanation: >-
Establishes ocular involvement across both segments as a defining feature
in a systematic review of 46 studies.
- reference: PMID:32920998
reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities"
explanation: >-
Eye abnormalities in infants who appeared unaffected at birth, which is why
ophthalmological screening is recommended irrespective of head size.
- category: Neurologic
name: Cerebellar Hypoplasia
phenotype_term:
preferred_term: Cerebellar hypoplasia
term:
id: HP:0001321
label: Cerebellar hypoplasia
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cerebellar hypoplasia is also common."
explanation: Records cerebellar involvement as a common postmortem finding.
- category: Neurologic
name: Ventriculomegaly
frequency: VERY_FREQUENT
description: >-
Ventriculomegaly in CZS has two distinct causes that the neuropathology
separates: ex-vacuo enlargement following parenchymal loss, and genuine
obstructive hydrocephalus from midbrain and aqueduct distortion. The second
can present with a large rather than small head, which is the reason head
circumference alone is an unreliable screen.
phenotype_term:
preferred_term: Ventriculomegaly
term:
id: HP:0002119
label: Ventriculomegaly
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion"
explanation: >-
Distinguishes the two mechanisms of ventricular enlargement and records
that one of them presents with a large head.
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
explanation: >-
Pooled frequency across 12 Brazilian cohorts, which is the basis for the
VERY_FREQUENT band on this phenotype.
- category: Neurologic
name: Seizures
frequency: FREQUENT
description: >-
Epilepsy is one of the two dominant post-natal complications of CZS (the
other is dysphagia) and is a direct clinical consequence of the cortical
malformation curated at the Impaired Neurogenesis and Congenital Cortical
Malformation node. Its phenotype is age-structured rather than uniform:
onset is typically after the third month, most often as infantile spasms,
with focal epilepsy predominating in the second year. Seizure control is
poor, which is why this is a driver of long-term care need and not only a
diagnostic feature.
phenotype_term:
preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
onset:
onset_category: INFANTILE
evidence:
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Epilepsy ranged from 30-80% of the children and dysphagia, from 22.2-67.7%."
explanation: >-
Pooled range across 12 Brazilian cohorts of children with Zika-related
microcephaly; the spread is the basis for the FREQUENT rather than
VERY_FREQUENT band.
- reference: PMID:32065676
reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Seizures typically began after the third month of life, usually as infantile spasms, with atypical electroencephalographic abnormalities."
explanation: >-
Establishes the timing and semiology, which is why onset is curated as
infantile rather than neonatal.
- reference: PMID:32065676
reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the main type of seizure was infantile spasms (83.1%)"
explanation: >-
Infantile spasms as the predominant seizure type in a 91-child cohort
followed for 24 months.
- reference: PMID:32065676
reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Overall, only 46.1% of the 65 children with epilepsy responded to treatment."
explanation: >-
Treatment response, recorded because poor seizure control is what makes
this phenotype a long-term burden rather than a transient one.
- reference: PMID:33320867
reference_title: "Congenital Zika syndrome: A systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "hydrocephalus, hypertonicity, and seizures; (b) in the osteoskeletal system: arthrogryposis and clubfoot"
explanation: >-
Independent corroboration from a systematic review of 46 studies, listing
seizures among the defining central nervous system signs.
- category: Neurologic
name: Spastic Hypertonia
frequency: VERY_FREQUENT
description: >-
Spastic hypertonia is the motor consequence of the same cortical lesion and
is the principal contributor to the cerebral-palsy phenotype these children
carry. It is distinct from the arthrogryposis curated separately: the
contractures are present at birth and neurogenic in origin, whereas
hypertonia is assessed after three months of age and progresses.
phenotype_term:
preferred_term: Hypertonia
term:
id: HP:0001276
label: Hypertonia
clinical_course: PROGRESSIVE
evidence:
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Spastic hypertonia was found in seven sites in which they were investigated, with a frequency of 100% in four sites"
explanation: >-
Frequency across the cohorts that assessed it; near-universal where
ascertained, which is the basis for the VERY_FREQUENT band.
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "spastic hypertonia (at >3 months of age), osteotendinous hyperreflexia"
explanation: >-
Records the case definition used, including the age threshold, which is
why this is not curated as a congenital finding.
- reference: PMID:33320867
reference_title: "Congenital Zika syndrome: A systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "hydrocephalus, hypertonicity, and seizures; (b) in the osteoskeletal system: arthrogryposis and clubfoot"
explanation: >-
Independent corroboration from a systematic review of 46 studies, listing
hypertonicity among the defining central nervous system signs.
- category: Gastrointestinal
name: Dysphagia
frequency: FREQUENT
description: >-
Swallowing dysfunction is the second dominant post-natal complication and
the one with the clearest mortality consequence, through aspiration
pneumonia. It is bulbar in origin, consistent with the brainstem
involvement recorded in the histopathology section, and frequently forces
gastrostomy.
phenotype_term:
preferred_term: Dysphagia
term:
id: HP:0002015
label: Dysphagia
evidence:
- reference: PMID:41460891
reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In the pooled analyses, dysphagia was common and observed in 46.9% of children."
explanation: >-
Pooled frequency across 12 cohorts, the basis for the FREQUENT band.
- reference: PMID:27509902
reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Dysphagia was present in six children (86%); two underwent gastrostomy and tracheostomy."
explanation: >-
Much higher frequency in the arthrogryposis series, consistent with
dysphagia tracking overall neurological severity rather than being an
independent feature.
- reference: PMID:33320867
reference_title: "Congenital Zika syndrome: A systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Dysphagia can increase the risk of bronchoaspiration, resulting in aspiration pneumonia or death from asphyxiation, requiring gastrostomy in the affected infants"
explanation: >-
States the mechanism by which dysphagia becomes fatal, which is why it is
curated as a phenotype in its own right rather than folded into feeding
difficulty.
- category: Neurologic
name: Global Developmental Delay
description: >-
Severe developmental delay across motor, language and cognitive domains is
the expected long-term outcome of CZS. No frequency band is recorded here
deliberately. The published pooled prevalences for neurodevelopmental delay
in ZIKV-exposed children are drawn from infants who were normocephalic and
apparently unaffected at birth, which is a different population from the
one this entry describes; applying those figures to CZS would understate
the delay substantially. The CZS-specific series are small and selected for
severity, so they establish that the delay is severe without supporting a
percentage.
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:39082517
reference_title: "Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Eighty-nine children with CZS and cerebral palsy undergoing rehabilitation showed evidence of severe developmental delays at the age of 1 year, according to the Bayley Scale of Infant and Toddler Development III (BSID-III)"
explanation: >-
Formal developmental assessment in a CZS cohort, establishing severity.
The cohort is selected (children already in rehabilitation for cerebral
palsy), which is why it supports the phenotype but not a frequency band.
- category: Growth
name: Small for Gestational Age
phenotype_term:
preferred_term: Small for gestational age
term:
id: HP:0001518
label: Small for gestational age
evidence:
- reference: PMID:33320867
reference_title: "Congenital Zika syndrome: A systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "abnormal visual function and low birthweight for gestational age"
explanation: Low birthweight for gestational age among the defining features in the systematic review.
prevalence:
- population: Symptomatic ZIKV-infected pregnant women, Brazil (Ribeirao Preto region)
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 2500.0
notes: >-
Major signs of congenital Zika syndrome in 13 of 513 fetuses (2.5%) of
symptomatic ZIKV-infected women in a prospective population-based cohort.
This is a risk per infected pregnancy, not a population prevalence of the
disease, and it is conditioned on the mother being symptomatic.
evidence:
- reference: PMID:32920998
reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Of these, 13 (2.5%; 95% CI 1.5-4.3) presented with major signs of congenital Zika syndrome (CZS)."
explanation: The proportion with major CZS signs, with its confidence interval.
- population: Liveborn infants of symptomatic ZIKV-infected women, Brazil
measure_type: BIRTH_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 3900.0
notes: >-
Microcephaly or other CNS malformation in 19 of 489 liveborn infants (3.9%).
Pregnancy losses occurred separately in 4.7% of the cohort, so the liveborn
denominator understates total adverse outcomes.
evidence:
- reference: PMID:32920998
reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Microcephaly or other CNS malformations were diagnosed in 1/4 (25.0%) stillbirths and in 19/489 (3.9%; 95% CI 2.5-5.9) of the liveborn infants."
explanation: Birth prevalence among liveborn infants, alongside the stillbirth figure.
diagnosis:
- name: Maternal gestational age at infection as the dominant risk determinant
description: >-
Timing of maternal infection is the single strongest predictor of fetal
outcome, and is the reason this entry treats first-trimester exposure as
the high-risk window rather than as a stylistic emphasis. Neuropathology
agrees with the epidemiology: lesion severity tracks gestational age at
infection.
evidence:
- reference: PMID:32920998
reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Fetal abnormalities were 14.0 (95% CI 7.6-26.0) times more likely with gestational infection occurring in ≤11 weeks."
explanation: Quantifies the timing dependence with an effect size and interval.
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester."
explanation: >-
Independent pathological confirmation of the same gradient, from tissue
rather than from outcome statistics.
- name: Screening of apparently unaffected exposed infants
description: >-
A normal examination at birth does not exclude CZS-spectrum injury. In
follow-up of infants classified as asymptomatic, a small proportion had eye
abnormalities or CNS imaging findings and a larger proportion had
neurological alert signs by three months. Hearing testing is likewise
recommended for all infants born to women with evidence of ZIKV infection,
including those who appear normal at birth.
evidence:
- reference: PMID:32920998
reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities, 1/207 (0.5%) had CNS imaging findings and 16/199 (8%) presented neurological alert signs."
explanation: Subclinical findings in infants who appeared unaffected, with denominators.
- reference: PMID:27585248
reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "all infants born to women with evidence of Zika virus infection during pregnancy should have their hearing tested, including infants who appear normal at birth"
explanation: The screening recommendation that follows from ascertainment-dependent detection.
histopathology:
- name: Destructive cortical injury with calcification and migration disturbance
description: >-
The postmortem picture is destructive rather than purely hypoplastic, which
is what distinguishes CZS from genetic primary microcephaly on tissue. It
combines extensive parenchymal destruction, calcification, disturbed
neuronal migration, and a reactive glial and microglial response, with
occasional perivascular lymphocytic cuffing extending to the meninges.
context: Postmortem CNS of fetuses and neonates infected early in gestation.
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges"
explanation: >-
The full histological description, including the inflammatory component
that a purely developmental account would not predict.
differential_diagnoses:
- name: Other congenital (TORCH) infections
description: >-
Congenital cytomegalovirus and toxoplasmosis produce overlapping
intracranial calcification, microcephaly, chorioretinal disease and hearing
loss, and are the principal differential. The pattern of calcification and
the presence of arthrogryposis help, but neither is decisive, so
discrimination rests on laboratory confirmation of the agent rather than on
imaging phenotype.
distinguishing_features:
- >-
Arthrogryposis with normal joints and neurogenic electromyographic findings
is characteristic of CZS and is not a usual feature of congenital CMV or
toxoplasmosis.
- >-
Sensorineural hearing loss occurs in CZS at a frequency similar to that seen
with other congenital viral infections, so it does not discriminate between
them.
evidence:
- reference: PMID:27585248
reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "which is similar to that seen in association with other congenital viral infections"
explanation: >-
States that the hearing-loss frequency does not separate CZS from the other
congenital infections, which is why it is listed as a non-discriminating
feature.
- name: Genetic primary microcephaly
description: >-
Autosomal recessive primary microcephaly converges on the same
progenitor-depletion endpoint but differs pathologically: CZS is a
destructive process with prominent cell death, necrosis and calcification,
whereas genetic primary microcephaly is hypoplastic without those features.
The distinction is made on tissue and imaging rather than on head
circumference.
distinguishing_features:
- >-
Calcification, parenchymal destruction and perivascular inflammation favour
congenital infection over a germline progenitor defect.
evidence:
- reference: PMID:29167994
reference_title: "Congenital Zika virus infection: a neuropathological review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia"
explanation: >-
The destructive, inflammatory signature that separates CZS from hypoplastic
genetic microcephaly on histology.
treatments:
- name: Supportive Care
description: >-
There is no specific antiviral therapy for congenital Zika syndrome.
Management is supportive and multidisciplinary, addressing feeding
difficulties, seizures, spasticity, and developmental needs.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
- name: Physical and Developmental Therapy
description: >-
Early rehabilitative and developmental therapy to support motor function
and mitigate the consequences of arthrogryposis and spasticity.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: physical therapy
term:
id: NCIT:C15302
label: Physical Therapy
animal_models:
- name: Dengue-immune cynomolgus macaque ZIKV pregnancy model
species: Cynomolgus macaque
genotype: Wild type, DENV-immune prior to ZIKV challenge
publication: PMID:37878671
description: >-
A nonhuman primate model of vertical transmission on a developmental
timeline close to the human one, used to ask why some ZIKV-exposed fetuses
are severely affected and others are not. Its answer is a maternal
immunological one that this entry otherwise has no account of: prior dengue
immunity worsens fetal outcome.
modeled_mechanisms:
- target: Impaired Neurogenesis and Congenital Cortical Malformation
relationship: RECAPITULATES
fidelity: HIGH
description: >-
Fetuses of DENV-immune macaques infected with ZIKV in early pregnancy
developed significantly more severe CZS than naive controls, with reduced
cortical thickness and increased neuronal death, haemorrhage, cellular
infiltration, calcification and lissencephaly — the same lesion set
reported in human postmortem material.
limitations: >-
The enhancement is demonstrated in macaques and has not been shown to
operate in human pregnancy, so it is a candidate explanation for the
variable human severity rather than an established one. The model also
cannot separate antibody-dependent enhancement from other consequences of
prior flavivirus exposure.
readouts:
- name: Fetal head circumference and biparietal diameter by serial ultrasound
target: Impaired Neurogenesis and Congenital Cortical Malformation
direction: DECREASED
interpretation: >-
In vivo growth measurement across gestation, directly comparable to the
human antenatal measure.
evidence:
- reference: PMID:37878671
reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Ultrasound measurements of head circumference and biparietal diameter measurements taken sequentially throughout pregnancy demonstrated CZS in fetuses of DENV-immune pregnant macaques."
explanation: The serial antenatal readout establishing microcephaly in the model.
- name: Fetal brain histopathology
target: Impaired Neurogenesis and Congenital Cortical Malformation
direction: INCREASED
interpretation: >-
The lesion set matches human CZS neuropathology, which is what makes the
model informative rather than merely a growth phenotype.
evidence:
- reference: PMID:37878671
reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "severe CZS enhanced by DENV immunity was typified by reduced cortical thickness and increased frequency of neuronal death, hemorrhaging, cellular infiltrations, calcifications, and lissencephaly in fetal brains"
explanation: The histological readouts, each of which has a human counterpart in this entry.
evidence:
- reference: PMID:37878671
reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We found significantly increased severity of congenital Zika syndrome (CZS) in fetuses of DENV-immune cynomolgus macaques infected with ZIKV in early pregnancy compared with naïve controls, which occurred despite no effect on maternal ZIKV infection or antibody responses."
explanation: >-
The core result, including the control that makes it a fetal rather than
a maternal effect: maternal infection and antibody responses were
unchanged.
discussions:
- discussion_id: gap_czs_human_model_translatability
prompt: >-
Which parts of the congenital Zika syndrome mechanism are directly supported
in human fetal disease, and which remain model-dependent findings from human
iPSC-derived neural progenitors, cerebral organoids, mouse embryos,
non-human-primate organoids, or organotypic fetal systems?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
- pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
- pathophysiology#Antiviral Innate Immune Activation
- pathophysiology#Viral Mitotic and Centrosome Cytopathy
- pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
- pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
rationale: >-
The disease pathograph now conforms to the viral neural progenitor cytopathy
module, but much of the causal resolution comes from experimental systems
rather than longitudinal human fetal material. Human autopsy anchors viral
brain invasion and destructive malformation, while iPSC-derived hNPCs,
cerebral organoids, mouse embryos, and non-human-primate organoids resolve
entry, TLR3/TBK1 signaling, centrosome perturbation, apoptosis, and strain
adaptation. This gap prevents a single model system from being treated as
complete proof of the human prenatal disease sequence.
evidence:
- reference: PMID:27279226
reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Mouse models often fail to reproduce the severely reduced brain size and
pathological alterations found in human patients21,22, likely due to
significant differences in gestation time and brain development between
the two species.
explanation: >-
The paper explicitly identifies species and developmental-context
differences that limit translation from mouse CZS models.
- reference: PMID:27279226
reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Finally, our data using a non-human primate organoids suggested that the
ZIKVBR might have experienced adaptive changes in human cells.
explanation: >-
Supports a strain- and host-cell-context mismatch gap for translating
organoid and animal findings to human congenital infection.
proposed_experiments:
- experiment_id: exp_czs_cross_model_fetal_alignment
name: CZS cross-model fetal-brain alignment experiment
description: >-
Compare matched ZIKV strains across human iPSC-derived cortical organoids,
hNPC/radial-glial cultures, ethically available fetal cortical tissue or
organotypic slices, and susceptible in vivo models, then map viral tropism,
TLR3/TBK1 signaling, centrosome perturbation, apoptosis, progenitor loss,
neurogenesis, and cortical thinning against human fetal autopsy endpoints.
experiment_type:
preferred_term: cross-model viral cortical malformation alignment experiment
model_systems:
- name: Human iPSC-derived cortical organoid ZIKV model
description: >-
Three-dimensional human cortical organoid system containing radial glia,
neural progenitors, and early cortical neurons exposed to clinically
relevant ZIKV strains.
experimental_model_type: ORGANOID
namo_type: namo:Organoid
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: cerebral cortex
term:
id: UBERON:0000956
label: cerebral cortex
cell_types:
- preferred_term: radial glial cell
term:
id: CL:0000681
label: radial glial cell
- preferred_term: neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
conditions:
- congenital Zika syndrome
- prenatal viral neural progenitor infection
cell_source: Human induced pluripotent stem cells
culture_system: Three-dimensional cortical organoid with controlled ZIKV exposure
- name: Human fetal cortical tissue benchmark
description: >-
Postmortem or organotypic fetal cortical material, where ethically and
legally available, used as a benchmark for viral localization, radial
glial vulnerability, apoptosis, calcification, and cortical tissue
architecture.
experimental_model_type: PRIMARY_CELL_CULTURE
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: cerebral cortex
term:
id: UBERON:0000956
label: cerebral cortex
cell_types:
- preferred_term: radial glial cell
term:
id: CL:0000681
label: radial glial cell
- preferred_term: neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
conditions:
- congenital Zika syndrome
cell_source: Human fetal cortical tissue
culture_system: Fetal cortical tissue benchmark or organotypic slice where available
perturbations:
- name: Matched congenital ZIKV strain exposure
target: pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
description: >-
Expose model systems to matched congenital outbreak isolates and
laboratory-passaged controls under controlled inoculum and developmental
timing.
readouts:
- name: Viral tropism and replication in radial glia and neural progenitors
target: pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
biological_processes:
- preferred_term: viral genome replication
term:
id: GO:0019079
label: viral genome replication
modifier: INCREASED
assays:
- preferred_term: viral RNA quantification
- preferred_term: immunostaining
- preferred_term: single-cell RNA sequencing
direction: POSITIVE
- name: Innate immune and centrosome cytopathy
target: pathophysiology#Viral Mitotic and Centrosome Cytopathy
biological_processes:
- preferred_term: toll-like receptor signaling pathway
term:
id: GO:0002224
label: toll-like receptor signaling pathway
modifier: INCREASED
- preferred_term: centrosome cycle
term:
id: GO:0007098
label: centrosome cycle
modifier: ABNORMAL
assays:
- preferred_term: phospho-TBK1 localization assay
- preferred_term: centrosome immunostaining
- preferred_term: single-cell RNA sequencing
direction: POSITIVE
- name: Progenitor survival and cortical growth
target: pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
biological_processes:
- preferred_term: apoptotic process
term:
id: GO:0006915
label: apoptotic process
modifier: INCREASED
- preferred_term: neurogenesis
term:
id: GO:0022008
label: neurogenesis
modifier: DECREASED
assays:
- preferred_term: cleaved caspase-3 immunostaining
- preferred_term: progenitor and neuron marker quantification
- preferred_term: cortical thickness measurement
direction: NEGATIVE
controls:
- name: Mock-infected controls
description: Matched model systems exposed to vehicle without infectious virus.
- name: Strain-matched heat-inactivated viral controls
description: Controls for innate immune stimulation not requiring productive infection.
decision_criterion: >-
The CZS mechanism is strengthened if human organoids, fetal tissue
benchmarks, and susceptible in vivo models show concordant radial-glial or
progenitor tropism, TLR3/TBK1 and centrosome perturbation, apoptosis,
progenitor depletion, reduced neurogenesis, and cortical thinning under
matched strain and developmental timing. Major divergence would localize
model-specific branches that should not be generalized to human CZS.
would_support:
- pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
- pathophysiology#Antiviral Innate Immune Activation
- pathophysiology#Viral Mitotic and Centrosome Cytopathy
- pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
- pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
would_refute:
- pathophysiology#Viral Mitotic and Centrosome Cytopathy
- pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
- discussion_id: gap_czs_specific_therapy
prompt: >-
No approved antiviral or disease-modifying therapy exists for congenital
Zika syndrome; candidate small molecules (e.g., nucleoside analogues) and
TLR3-pathway modulation have shown effects only in experimental models.
Which interventions, if any, can interrupt the progenitor-cytopathy cascade
within the narrow prenatal therapeutic window?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Antiviral Innate Immune Activation
- pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
rationale: >-
Experimental evidence (e.g., TLR3 inhibition reducing ZIKV phenotypes in
organoids) suggests mechanistically rational intervention points, but no
therapy has translated to human prenatal use, and the destructive,
early-onset nature of the progenitor cytopathy makes the therapeutic window
extremely narrow. This gap motivates prevention (vector control, avoidance
of exposure in pregnancy) as the current mainstay.
- discussion_id: mismatch_czs_tnt_placental_transmission
prompt: >-
Does tunneling-nanotube-mediated viral spread operate in the human placenta,
and how much of the mouse placental-injury phenotype transfers to human
congenital Zika disease?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Tunneling Nanotube-Mediated Intercellular Viral Spread
- pathophysiology#Placental Infection
- pathophysiology#Placental Architectural and Functional Disruption
- pathophysiology#Fetal Growth Restriction
- pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
rationale: >-
The TNT arm of transplacental dissemination is established entirely in mouse
pregnancy models, by comparing a TNT-competent virus with an NS1
residue-40-52 TNT-deficient mutant. Two distinct translational questions
follow. First, TNTs have not been demonstrated to carry ZIKV between cells
in human placental tissue in vivo, so the mechanism is a strong candidate
rather than an established human route. Second, and more concretely, the
architectural readout does not transfer at all: the junctional zone and
labyrinth are compartments of the rodent placenta with no direct human
homolog, so "altered junctional-to-labyrinth architecture" cannot be
restated as a human placental finding. The nearest human comparison points
the other way: in full-term placentas from three ZIKV-infected women, viral
NS3 antigen localized to Hofbauer cells while the placentas showed no
anatomic defects (PMID:31709049, the publication behind the GSE139181
dataset already curated in this entry) — a small series, and not a test of
the TNT mechanism, but not obviously the same picture either. Fetal growth
restriction is therefore curated as an ORGANISM-scale pathophysiology node
carrying model-organism evidence, and is deliberately absent from
`phenotypes:`, which would require human evidence.
proposed_experiments:
- experiment_id: exp_czs_tnt_human_placenta
name: Detection of ZIKV-laden tunneling nanotubes in human placental explants
description: >-
Live imaging and correlative electron microscopy of ZIKV-infected primary
human trophoblast and placental explant cultures, scoring actin-rich
intercellular conduits carrying viral components, with the NS1
residue-40-52 TNT-deficient mutant as the negative control.
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Here, we investigated the in vivo role of TNTs in ZIKV maternal-fetal transmission using complementary pregnancy models."
explanation: Establishes that the in vivo evidence for the TNT arm comes from animal pregnancy models rather than human tissue.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
explanation: Names the junctional-to-labyrinth readout, which is a rodent placental compartment measure with no human equivalent.
- reference: PMID:31709049
reference_title: "Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Although ZIKV NS3 antigens co-localised to placental Hofbauer cells, the placentas showed no anatomic defects."
explanation: >-
The human placental comparison invoked in this mismatch. Infected human
placentas carried viral antigen without the structural defects the mouse
models show.
- discussion_id: gap_czs_ns1_tnt_therapeutic_target
prompt: >-
Is the NS1 determinant of tunneling-nanotube formation (residues 40-52) a
tractable antiviral target for preventing transplacental ZIKV transmission,
and does the same TNT route operate in other vertically transmitted viruses?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Tunneling Nanotube-Mediated Intercellular Viral Spread
rationale: >-
A discrete viral protein determinant whose loss reduces dissemination,
placental injury, and fetal growth restriction without abolishing viral
viability is an unusually clean target hypothesis, and it addresses the
transmission step rather than the downstream progenitor cytopathy — a much
wider therapeutic window than the one the existing therapy gap describes.
Nothing here has been tested as an intervention: the evidence is a
genetically engineered mutant virus, not a drug or an antibody, and no
NS1-directed agent has been shown to block TNT formation. The authors also
raise, without testing, whether TNTs matter for other vertically transmitted
or emerging viruses; that generalization has no evidence in this entry and
should not be curated onto other disease entries on the strength of this
paper alone.
evidence:
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These findings identify TNTs as a previously underappreciated pathway of viral transmission during pregnancy and suggest new therapeutic targets."
explanation: The therapeutic-target claim is the authors' proposal, not a tested intervention, which is what makes this a gap rather than a treatment entry.
- reference: PMID:42627154
reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "More broadly, TNTs may contribute to the pathogenesis of other vertically transmitted or emerging viral infections."
explanation: Records the cross-pathogen generalization as an explicitly speculative statement.
- discussion_id: gap_czs_dengue_immunity_enhancement
prompt: >-
Does pre-existing maternal dengue immunity worsen fetal outcome in human
congenital Zika syndrome, as it does in macaques?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
- pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
- animal_models#Dengue-immune cynomolgus macaque ZIKV pregnancy model
rationale: >-
Why some ZIKV-exposed fetuses are severely affected and others are not is
the largest unexplained variance in this disease, and the entry's timing
account does not fully cover it. A nonhuman primate experiment supplies a
candidate: fetuses of dengue-immune macaques infected in early pregnancy
developed significantly worse CZS than naive controls, with no difference in
maternal infection or antibody response — locating the effect in the fetus
rather than in maternal viral control.
The translational question is unusually consequential because ZIKV and DENV
co-circulate across most of the affected geography, so a large share of
women entering a Zika outbreak are dengue-immune. If the enhancement operates
in humans, prior dengue serostatus would be a risk stratifier available
before conception and would also bear on flavivirus vaccination strategy in
women of childbearing age. If it does not, the macaque result localises a
species-specific branch that should not inform human counselling.
This is recorded as a mismatch rather than a knowledge gap because the
evidence exists and is strong in the model; what is unknown is whether it
transfers.
proposed_experiments:
- experiment_id: exp_czs_denv_serostatus_stratified_cohort
name: DENV-serostatus-stratified prospective cohort of ZIKV-infected pregnancies
description: >-
In a prospective cohort of pregnancies with confirmed ZIKV infection,
determine pre-pregnancy or first-trimester DENV serostatus and compare the
incidence and severity of CZS between DENV-immune and DENV-naive mothers,
stratifying by gestational age at infection so the two risk factors are not
confounded.
would_support:
- pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
supporting_outcome:
- >-
CZS is more frequent or more severe in the offspring of DENV-immune
mothers after adjustment for timing, supporting transfer of the macaque
enhancement to human pregnancy.
refuting_outcome:
- >-
CZS incidence and severity are independent of maternal DENV serostatus,
indicating the enhancement is model-specific and should not be used for
human risk stratification.
datasets:
- accession: geo:GSE234062
title: Human Otic progenitor cell models of congenital hearing loss applied to to Zika virus and cytomegalovirus infections
description: Congenital hearing loss is a common chronic condition affecting children in both developed and developing nations. In many cases, congenital hearing loss is ultimately attributed to viral infection, most often by cytomegalovirus (CMV), but also in Congenital Zika Syndrome (CZS). The mechanisms by which CMV and ZIKV virus cause these cranial developmental defects have not been elucidated. Inner ear development has been particularly difficult to study, given the inaccessibility and scarcity of the tissue in animal models or on human autopsy; however, it is now possible to culture stem-cell derived otic progenitor cells (OPCs).
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: BULK_RNA_SEQ
sample_count: 36
publication: PMID:38440980
notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE102128
title: RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome
description: Congenital Zika syndrome (CZS), caused by Zika virus (ZIKV) infection, has been associated to impairment of early brain development, particularly related to neural progenitor cells (NPCs) survival and growth. In this work we report in a high-throughput manner (RNA-Seq) the differences in the transcriptomes of hiPSCs(human induced pluripotent stem cells)-derived NPCs from 3 pairs of discordant twins for Congenital Zika syndrome (CZS).
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: BULK_RNA_SEQ
sample_count: 6
publication: PMID:29396410
notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE139181
title: Transcriptomics analysis of trimester-specific full-term placentas from three Zika virus-infected women
description: Effects of Zika virus (ZIKV) infection on placental development during pregnancy are unclear. In this study, full-term placentas from three women, each infected with ZIKV during specific pregnancy trimesters, were harvested for anatomic, immunologic and transcriptomic analysis. Each woman exhibited a unique immune response with raised IL-1RA, IP-10, EGF and RANTES expression, and neutrophil numbers during the acute infection phase. Although ZIKV NS3 antigens co-localized to placental Hofbauer cells, the placentas showed no anatomical defects.
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: BULK_RNA_SEQ
sample_count: 33
publication: PMID:31709049
notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
references:
- reference: PMID:26862926
title: "Zika Virus Associated with Microcephaly."
- reference: PMID:26952870
title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
- reference: PMID:27038591
title: "Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells."
- reference: PMID:27064148
title: "Zika virus impairs growth in human neurospheres and brain organoids."
- reference: PMID:27066743
title: "Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection."
- reference: PMID:27162029
title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
- reference: PMID:27179424
title: "Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice."
- reference: PMID:27247001
title: "Zika Virus Infects Human Placental Macrophages."
- reference: PMID:27279226
title: "The Brazilian Zika virus strain causes birth defects in experimental models."
- reference: PMID:27443522
title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
- reference: PMID:27509902
title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
- reference: PMID:27568284
title: "Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia."
- reference: PMID:27585248
title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
- reference: PMID:28132835
title: "Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids."
- reference: PMID:29167994
title: "Congenital Zika virus infection: a neuropathological review."
- reference: PMID:30252119
title: "Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss among Children at 3 and 24 Months Post-Partum."
- reference: PMID:31709049
title: "Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women."
- reference: PMID:32065676
title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
- reference: PMID:32920998
title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
- reference: PMID:33320867
title: "Congenital Zika syndrome: A systematic review."
- reference: PMID:37878671
title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
- reference: PMID:39082517
title: "Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development."
- reference: PMID:41460891
title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
- reference: PMID:42627154
title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
Congenital Zika syndrome (CZS) is a specific pattern of congenital anomalies and long-term neurodevelopmental disabilities caused by vertical (mother-to-child) transmission of Zika virus (ZIKV) during pregnancy, with the central nervous system (CNS) as the primary target and frequent multisystem involvement (ocular, musculoskeletal, feeding/swallowing, and other neurologic comorbidities). (martelli2024clinicalspectrumof pages 1-2, crisantolopez2023congenitalzikasyndrome pages 1-2)
Evidence in this report is derived from both (i) aggregated resources (systematic reviews, meta-analyses, surveillance reviews) and (ii) primary cohorts (prospective cohorts, pooled individual-participant data analyses, caregiver studies using validated scales). (mirandafilho2025characterizationof843 pages 2-3, rabe2025areviewof pages 4-5, melo2023congenitalzikasyndrome pages 11-12)
Primary cause: In utero ZIKV infection (vertical transmission), which can occur even when maternal infection is asymptomatic; congenital manifestations arise from placental infection and fetal neurotropism with injury to neural progenitors and neurodevelopmental disruption. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5)
Evidence for protective factors is limited and heterogeneous. In one longitudinal cohort of normocephalic preschool children in Colombia (not restricted to CZS cases), daycare/school attendance was associated with a lower risk of neurodevelopmental delay, while prenatal ZIKV exposure was not significantly associated with delay in that cohort; this represents a social/environmental protective association rather than biological protection. (shah2024analysisofcongenital pages 13-15)
A key hypothesized interaction is prior flavivirus immunity and antibody-dependent enhancement (ADE) mechanisms at the maternal–fetal interface, which may facilitate placental infection/transfer via Fcγ receptor pathways (conceptualized in placental-interface reviews). (wong2025zikavirusand pages 2-3)
CZS is defined by a recognizable phenotype including severe/disproportionate microcephaly, characteristic neuroimaging abnormalities (calcifications, ventriculomegaly, cortical atrophy/malformations), ocular lesions (retinal/optic nerve), congenital contractures (arthrogryposis/clubfoot), and frequent neurologic comorbidities such as epilepsy and dysphagia. (martelli2024clinicalspectrumof pages 1-2, martelli2024clinicalspectrumof pages 2-3)
A consolidated phenotype-frequency table with suggested HPO terms and quantitative ranges is provided below.
| Domain | Specific phenotype (suggested HPO term) | Quantitative estimate(s) | Population / study type | Notes | Supporting citation IDs |
|---|---|---|---|---|---|
| CNS | Microcephaly (HP:0000252) | ~4% absolute risk of microcephaly after confirmed maternal ZIKV infection; baseline pre-epidemic microcephaly ~2.0/10,000 newborns | Brazil meta-analysis/review summarized in 2024 update | Signature phenotype; risk estimate refers to infected pregnancies/offspring follow-up | (martelli2024clinicalspectrumof pages 1-2) |
| CNS | Severe microcephaly (HP:0011451) | 384/601 (63.9%) among children with microcephaly at birth; moderate 217/601 (36.1%) | IPD meta-analysis of 12 Brazilian cohorts, n=843 children with Zika-related microcephaly | Captures severity distribution among those already affected | (mirandafilho2025characterizationof843 pages 2-3) |
| CNS | Postnatal microcephaly (HP:0000252) | 172/843 (20.4%) | IPD meta-analysis of 12 Brazilian cohorts | Highlights progression after birth in some exposed infants | (mirandafilho2025characterizationof843 pages 2-3) |
| Neuroimaging | Intracranial calcifications (HP:0002514) | ~80% across pooled Brazilian cohorts; 94% in systematic clinicopathologic review | IPD meta-analysis; systematic review of Brazilian outbreak cohorts | One of the most consistent structural markers of severe CZS | (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) |
| Neuroimaging | Ventriculomegaly (HP:0002119) | ~80% across pooled cohorts; 89% in systematic clinicopathologic review | IPD meta-analysis; systematic review | Often co-occurs with calcifications and cortical atrophy | (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) |
| Neuroimaging | Cortical atrophy / reduced cerebral parenchyma (HP:0007373, HP:0002059) | ~50% cortical atrophy/developmental disorders across pooled cohorts; reduced cerebral parenchyma 86%; malformation of cortical development/lack of gyri 78% | IPD meta-analysis; systematic review | Marks severe prenatal brain disruption | (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) |
| CNS | Neurological alteration of any type | 18.7% | Zika Brazilian Cohorts pooled pregnancy/child follow-up | Broader than microcephaly alone | (martelli2024clinicalspectrumof pages 3-4) |
| CNS | Any abnormality after antenatal exposure | 24.7% had ≥1 alteration | Zika Brazilian Cohorts pooled pregnancy/child follow-up | Includes isolated abnormalities; not restricted to classic CZS | (martelli2024clinicalspectrumof pages 3-4) |
| CNS | Epilepsy / seizures (HP:0001250) | 37.7%–71.4% in reviewed cohorts; 71.4% cumulative incidence within 2 years in one microcephaly cohort; 30%–80% across 12-cohort IPD; 91% in clinicopathologic review | Brazil cohorts, systematic reviews, IPD meta-analysis | Often early-onset; epileptic spasms may begin after 3 months | (martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) |
| Ocular | Ocular abnormalities overall (HP:0000478) | 21.4%–70%; about one-third in one multisite Brazilian study | Brazil cohorts/review | Some affected infants had ocular findings without microcephaly | (martelli2024clinicalspectrumof pages 2-3) |
| Ocular | Fundus abnormalities (HP:0000580) | 0%–67.1% | IPD meta-analysis of 12 Brazilian cohorts | Wide heterogeneity across sites | (mirandafilho2025characterizationof843 pages 2-3) |
| Ocular | Optic nerve abnormalities (HP:0001138) | 0%–36.5% across cohorts; 67% in systematic clinicopathologic review | IPD meta-analysis; systematic review | Includes optic nerve pallor/atrophy | (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) |
| Ocular | Retinal lesions / chorioretinal atrophy/scarring (HP:0000556, HP:0007703) | 79% retinal lesions in systematic review; examples: chorioretinal atrophy 11/17 eyes (64.7%), macular chorioretinal atrophy/scarring 45.8% | Systematic review; outbreak case series summarized in review | Major cause of visual impairment | (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12) |
| Auditory | Hearing abnormality (HP:0000365) | 0%–50% across cohorts; ~20% in systematic clinicopathologic review | IPD meta-analysis; systematic review | Conductive or sensorineural deficits reported | (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 1-3, shah2024analysisofcongenital pages 13-15) |
| Musculoskeletal | Arthrogryposis / congenital contractures (HP:0002804, HP:0001371) | ~15% in systematic review; 19.0% (n=4) in one summarized series | Systematic review; case series summarized in review | Commonly associated with severe CNS disease and hypertonia | (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12) |
| Musculoskeletal | Hypertonia / spasticity (HP:0001276, HP:0001257) | Hypertonia up to 92%; spasms/spasticity 97%; appendicular hypertonia 94.8% in one series | Systematic review; summarized cohorts | Major contributor to cerebral palsy phenotype | (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12) |
| Musculoskeletal | Quadriparesis / severe motor impairment (HP:0002510, HP:0001270) | Quadriparesis 92%; one cohort reported 81% severe motor function impairment | Systematic review; Brazil cohort review | Usually evident in infancy/early childhood | (shah2024analysisofcongenital pages 13-15, martelli2024clinicalspectrumof pages 3-4) |
| Feeding-Growth | Dysphagia / swallowing dysfunction (HP:0002015) | 17.9%–70% across reviews; 22.2%–67.7% across 12-cohort IPD; oropharyngeal dysphagia 79.3% in microcephaly vs 8.5% in normocephalic peers | Brazil cohorts, review, IPD meta-analysis | Major driver of malnutrition and aspiration risk; ~20% required alternative feeding by age 2 | (martelli2024clinicalspectrumof pages 3-4, martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3) |
| Feeding-Growth | Low birth weight (HP:0001518) | 10%–43.8% across cohorts; 23.9% in one infant cohort up to 12 months | IPD meta-analysis; observational cohort | Reflects prenatal growth effects and heterogeneity | (mirandafilho2025characterizationof843 pages 2-3) |
| Feeding-Growth | Linear growth deficit / short stature (HP:0004322) | 39.1% of length-for-age measurements below deficit threshold in one cohort; stunting in literature 14.3%–57.1% | Infant cohort; systematic review of malnutrition studies | Often linked to dysphagia and feeding difficulty | (mirandafilho2025characterizationof843 pages 2-3) |
| Feeding-Growth | Underweight / wasting (HP:0004325) | Underweight 14.3%–54.4%; wasting 4.3%–48.0% | Systematic review of observational studies in children with CZS | Reflects chronic nutritional vulnerability | (mirandafilho2025characterizationof843 pages 2-3) |
| Other | Urological impairment | Frequency not pooled; repeatedly reported as common comorbidity | Brazil cohort review | Included as part of broader multisystem CZS spectrum | (martelli2024clinicalspectrumof pages 1-2) |
| Other | Hospitalization burden | 41.4% in children with microcephaly vs 16.2% in normocephalic peers | Brazil cohorts summarized in review | Likely reflects feeding, neurologic, and respiratory complications | (martelli2024clinicalspectrumof pages 3-4) |
| Other | Mortality | 11.3-fold higher mortality up to 36 months in children with CZS / Zika-related microcephaly vs unexposed peers | Systematic review summary | Severe disease substantially increases early-childhood mortality | (shah2024analysisofcongenital pages 13-15) |
| Epidemiology statistic | Estimate | Population / timeframe | Notes | Supporting citation IDs |
|---|---|---|---|---|
| CZS proportion among ZIKV-infected pregnancies | 4.65% (95% CI 3.38–6.67%) | Systematic review/meta-analysis of ZIKV epidemiology | Pooled estimate for CZS among infected pregnancies | (mccain2026asystematicreview pages 1-2, mccain2026asystematicreview pages 7-7) |
| Countries/territories with documented autochthonous mosquito-borne ZIKV transmission | 92 | Global status as of Dec 2023 | Transmission likely underrecognized because many infections are asymptomatic/mild | (rabe2025areviewof pages 1-2, rabe2025areviewof pages 3-4) |
| Brazil confirmed CZS cases | 1,858 confirmed; 2,960 suspected under investigation | 2015 to epidemiological week 31 of 2023 | National surveillance; cases fell sharply after 2017 | (martelli2024clinicalspectrumof pages 1-2) |
| Brazil 2023 reported Zika cases | 54,116 cases; incidence 25/100,000; 6,201 laboratory confirmed | Brazil, 2023 | Brazil accounted for 97% of reported Americas cases in preliminary 2023 surveillance | (rabe2025areviewof pages 4-5) |
| Preliminary Americas Zika cases in 2023 | 55,813 cases from 14 countries; 4 deaths | Americas, 2023 preliminary surveillance | 11% laboratory confirmed | (rabe2025areviewof pages 4-5) |
Table: These tables summarize the main congenital Zika syndrome phenotypes with quantitative frequency estimates and the most useful recent epidemiology statistics. They are designed for rapid knowledge-base extraction and link each major claim to supporting context IDs.
Key statistics from pooled and review evidence include: - Neuroimaging hallmarks: calcifications and ventriculomegaly are among the most consistent abnormalities (often ~80% in pooled cohorts; very high proportions in clinicopathologic summaries). (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) - Epilepsy: reported prevalence varies with ascertainment/severity and follow-up, ranging from ~30–80% across pooled cohorts and up to ~71% cumulative incidence by age 2 in some microcephaly cohorts. (martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3) - Feeding/swallowing dysfunction: dysphagia is frequently reported (broad ranges across cohorts/reviews), with severe oropharyngeal dysphagia particularly enriched among children with Zika-related microcephaly. (martelli2024clinicalspectrumof pages 3-4)
A 2023 integrative review (31 studies) described caregiver burdens spanning social, psychological, economic/material, and health domains, with quantified mental-health burdens in some studies (e.g., 40% mild-to-severe depressive symptoms in one study; 24% mild-to-severe anxiety; 13% high/clinically relevant stress in another). Publication date: 2023-05; URL: https://doi.org/10.1590/1413-81232023285.14852022en (melo2023congenitalzikasyndrome pages 11-12)
CZS is not classically a monogenic disease; the causal factor is infectious (ZIKV). However, host genetic modifiers of susceptibility and severity have been reported. (santos2023associationbetweengenetic pages 1-2, marques2025geneticmodifiersof pages 10-13)
A 2023 case–control candidate-gene study (Brazil; 245 individuals including mother–infant pairs) reported associations between: - TREM1 rs2234246 with CZS occurrence (e.g., CC genotype OR reported ~4.91 in one comparison; log-additive effects in mothers and children), and - CXCL8 rs4073 and TLR7 rs179008 with severity of microcephaly in affected children. Publication date: 2023-03; URL: https://doi.org/10.1038/s41598-023-30342-3 (santos2023associationbetweengenetic pages 4-5, santos2023associationbetweengenetic pages 1-2)
A 2025 scoping review summarized 23 candidate genes across 13 studies (mixed designs including WES, discordant twin transcriptomics, and candidate-gene cohorts) as potential modifiers; named examples include MTOR (rs2295079) and immune-pathway polymorphisms (e.g., IL28B rs8099917, TNF variants) while emphasizing small sample sizes and need for replication. Publication date: 2025-01; URL: https://doi.org/10.1101/2025.01.02.25319896 (marques2025geneticmodifiersof pages 10-13)
No specific epigenetic signatures or recurrent chromosomal abnormalities were identified in the retrieved evidence for this run.
Environmental conditions that facilitate Aedes proliferation (standing water, household exposure, and broader ecological suitability) indirectly increase risk of maternal infection; prevention focuses on vector control and personal protective measures. (crisantolopez2023congenitalzikasyndrome pages 8-10)
Trigger: Maternal ZIKV infection during pregnancy → placental infection and vertical transmission → fetal CNS infection and/or placental insufficiency/inflammatory injury → neurodevelopmental disruption → congenital malformations and long-term neurologic disability. (wong2025zikavirusand pages 3-5, wong2025zikavirusand pages 1-2)
Key mechanistic steps supported by recent reviews: 1. Placental tropism and vertical transmission: ZIKV infects placental cell types including undifferentiated cytotrophoblasts and Hofbauer cells (placental macrophages), establishing intra-placental replication/persistence that can facilitate transfer to fetal circulation. (wong2025zikavirusand pages 3-5) 2. Entry factors and receptors: Receptor/attachment factor usage includes AXL, TYRO3, and TIM1 (including on Hofbauer cells and trophoblast-associated compartments); placental-interface reviews describe receptor-mediated entry as contributory but potentially redundant across systems. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5) 3. Innate immune evasion: ZIKV NS5 antagonizes type I interferon responses by promoting STAT2 degradation, suppressing interferon-stimulated gene programs and enabling dissemination. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5) 4. Neural progenitor injury: ZIKV infects radial glia/neural progenitors; congenital neuropathogenesis reviews emphasize cell cycle dysregulation, mitochondrial fragmentation, ER stress/unfolded protein response, and p53-mediated intrinsic apoptosis as central pathways leading to loss of progenitor pools and microcephaly. (metzler2024zikavirusneuropathogenesis—research pages 1-2) 5. Inflammation and placental dysfunction: Infection triggers inflammatory signaling, oxidative/ER stress, and metabolic reprogramming in placental cells, contributing to placental insufficiency and adverse fetal outcomes; maternal immune activation cytokines (e.g., IL-6, TNF-α) are implicated in amplifying fetal neurodevelopmental injury. (wong2025zikavirusand pages 1-2, wong2025zikavirusand pages 3-5)
Placenta (trophoblast lineages and fetal macrophages) is a key site of replication/persistence relevant to transmission; fetal neurogenic zones (ventricular/subventricular regions) are implicated in neural progenitor injury. (wong2025zikavirusand pages 3-5, shah2024analysisofcongenital pages 13-15)
The retrieved evidence did not provide a consistent, pooled sex ratio for CZS; cohort-level details exist but were not systematically extractable from the provided snippets.
Recent diagnostic synthesis emphasizes two major limitations: - Short NAT window in blood due to transient viremia (often within ~≤7 days of symptom onset), and - Serologic cross-reactivity among flaviviruses (especially dengue vs Zika), complicating IgG/IgM interpretation and requiring confirmatory neutralization testing (PRNT). Publication date: 2025-04; URL: https://doi.org/10.1038/s44298-025-00114-z (madere2025flavivirusinfectionsand pages 5-6, madere2025flavivirusinfectionsand pages 1-2)
Brain CT/MRI abnormalities (cortical atrophy, ventriculomegaly, calcifications) are used as structural markers of severity and part of clinical evaluation of suspected CZS. (martelli2024clinicalspectrumof pages 1-2)
When congenital infection is suspected, evaluation should exclude other teratogenic infections (e.g., CMV, rubella, toxoplasmosis, syphilis), which is explicitly recommended in clinical management summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10)
Outcomes vary markedly by whether an infant has classic CZS/microcephaly versus antenatal exposure without congenital findings. - In a matched cohort (Brazil), in utero exposure was associated with IRR 2.7 (95% CI 1.4–5.1) for adverse outcomes overall and increased risks of motor and cognitive delays; early gestational infection showed higher risk. (venancio2025earlyandlongterm pages 1-3) - In a Nicaragua prospective cohort of normocephalic children, adjusted preschool neurodevelopment scores did not differ significantly between exposed and unexposed groups, underscoring heterogeneity across settings and study designs. Publication date: 2024-07; URL: https://doi.org/10.1016/S2214-109X(24)00176-1 (max2024neurodevelopmentinpreschool pages 1-3)
A 2024 systematic clinicopathologic review summarized markedly increased early-childhood mortality in severe CZS presentations (reported as ~11.3-fold higher risk up to 36 months in one cited estimate). (shah2024analysisofcongenital pages 13-15)
There is no specific curative treatment for CZS; management is supportive and multidisciplinary, requiring constant monitoring, early intervention/rehabilitation, feeding/nutrition management, and management of epilepsy and motor impairment. (crisantolopez2023congenitalzikasyndrome pages 1-2, shah2024analysisofcongenital pages 13-15)
Suggested MAXO terms (examples; not exhaustively evidenced in retrieved text): - MAXO:0000102 (rehabilitation), MAXO:0000427 (physical therapy), MAXO:0000415 (speech therapy), MAXO:0000600 (nutritional support), MAXO:0000747 (seizure management) — included as ontology suggestions based on the supportive-care emphasis. (shah2024analysisofcongenital pages 13-15, crisantolopez2023congenitalzikasyndrome pages 8-10)
Preclinical evidence summarized in an animal-model review notes repurposed antivirals (e.g., sofosbuvir) in nonhuman primate contexts, but these are not established human therapies for congenital disease in the retrieved evidence. (gardinali2025congenitalzikavirus pages 3-4)
Prevention focuses on reducing maternal infection risk: - Vector control and personal protection: reduction of breeding sites, window/door screens, bed nets, covering clothing, and repellents (e.g., DEET, picaridin/icaridin) are recommended in clinical prevention summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10) - Reproductive counseling and sexual transmission precautions: guidance on delaying conception after exposure and barrier protection for partners is described in clinical guidance summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10)
Multiple Zika vaccines have been evaluated in clinical trials; several have completed early-phase studies: - mRNA vaccine (mRNA-1893; Moderna): Phase 2, randomized observer-blind placebo-controlled; COMPLETED; enrollment 808; completion date 2024-07-26; results posted Sept 2025. ClinicalTrials.gov: NCT04917861. (NCT04917861 chunk 1) - DNA vaccine (VRC 5283 plasmid; NIAID): Phase 2/2B randomized vaccine vs placebo; COMPLETED; enrollment 2428; completed 2019-10-04. ClinicalTrials.gov: NCT03110770. (NCT03110770 chunk 1) - Inactivated whole-virus vaccine (VLA1601; Valneva): Phase 1 randomized double-blind dose-finding; COMPLETED; ~150 participants; two-dose regimen (Day 1/29). ClinicalTrials.gov: NCT06334393. (NCT06334393 chunk 1)
These trials are aimed at preventing ZIKV infection (and downstream congenital disease) but do not constitute current standard-of-care prevention in routine practice given the absence of a licensed vaccine in the retrieved evidence. (rabe2025areviewof pages 1-2, NCT04917861 chunk 1)
ZIKV congenital outcomes are modeled across species; the evidence here primarily supports experimental susceptibility rather than naturally occurring veterinary disease burdens.
Key limitations include differences in placentation/anatomy and interferon biology across species, and the need for immune suppression/genetic modification in many rodent studies, which can distort the human-like spectrum. (gardinali2025congenitalzikavirus pages 2-3, metzler2024zikavirusneuropathogenesis—research pages 13-14)
References
(martelli2024clinicalspectrumof pages 1-2): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.
(crisantolopez2023congenitalzikasyndrome pages 1-2): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.
(martelli2024clinicalspectrumof pages 2-3): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.
(NCT03110770 chunk 4): VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents. National Institute of Allergy and Infectious Diseases (NIAID). 2017. ClinicalTrials.gov Identifier: NCT03110770
(crisantolopez2023congenitalzikasyndrome pages 8-10): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.
(mirandafilho2025characterizationof843 pages 2-3): Demócrito de Barros Miranda-Filho, Ricardo Arraes de Alencar Ximenes, Ulisses Ramos Montarroyos, Marília Rosa Abtibol-Bernardino, Elizabeth B. Brickley, Celina Maria Turchi Martelli, Laura Cunha Rodrigues, Thália Velho Barreto de Araújo, Liana O. Ventura, Mariana Carvalho Leal, Darci Neves Santos, Letícia Marques dos Santos, Lucas Monteiro Santos, Mariana Rabelo Gomes, Isadora Cristina de Siqueira, Letícia Serra, Débora Patrícia Medeiros Santos Rios, Alessandra Carvalho, Antônio Moura Silva, Patrícia Silva Sousa, Marizélia Costa Ribeiro, Marcos Garcia Campos, Saulo Duarte Passos, Ana Paula Paschoalicchio Bertozzi, Rosa Estela Gazeta, Daniel T. Catalan, Ricardo Queiroz Gurgel, Aline de Siqueira Alves Lopes, Andrea Monteiro Correia Medeiros, Patrícia Brasil, Karin Nielsen-Saines, Zilton Vasconcelos, Andrea Araújo Zin, Marisa Márcia Mussi-Pinhata, Silvia Fabiana Biason de Moura Negrini, Bento Vidal de Moura Negrini, Carla Andrea Cardoso Tanuri Caldas, Daniela Vivacqua, Bernadete Perez Coelho, Lucíola de Fátima Albuquerque de Almeida Peixoto, Camila Bôtto-Menezes, Silvana Gomes Benzecry, Consuelo Silva de Oliveira, Joelma Karin Sagica Fernandes Paschoal, Emilene Monteiro Furtado Serra, Luna Thais Sousa Gomes, Maria Elisabeth Moreira, and Cristina Barroso Hofer. Characterization of 843 children with zika-related microcephaly in the first three years of life: an individual participant data meta-analysis of 12 cohorts in the zika brazilian cohorts consortium. PLOS Global Public Health, 5(12):e0005425, Dec 2025. URL: https://doi.org/10.1371/journal.pgph.0005425, doi:10.1371/journal.pgph.0005425. This article has 1 citations and is from a peer-reviewed journal.
(rabe2025areviewof pages 4-5): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.
(melo2023congenitalzikasyndrome pages 11-12): Ana Paula Lopes de Melo, Tereza Maciel Lyra, Jessyka Mary Vasconcelos Barbosa, and Thália Velho Barreto de Araújo. Congenital zika syndrome and family impacts: an integrative review. Ciência & Saúde Coletiva, May 2023. URL: https://doi.org/10.1590/1413-81232023285.14852022en, doi:10.1590/1413-81232023285.14852022en. This article has 14 citations.
(crisantolopez2023congenitalzikasyndrome pages 4-5): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.
(wong2025zikavirusand pages 3-5): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.
(venancio2025earlyandlongterm pages 1-3): Fabio Antonio Venancio, Maria Eulina Quilião, Sanny Cerqueira de Oliveira Gabeira, Amanda Torrentes de Carvalho, Silvia Helena dos Santos Leite, Sheila Maria Barbosa de Lima, Nathalia dos Santos Alves, Luma da Cruz Moura, Waleska Dias Schwarcz, Adriana de Souza Azevedo, Luiz Henrique Ferraz Demarchi, Marina Castilhos Souza Umaki Zardin, Gislene Garcia de Castro Lichs, Deborah Ledesma Taira, Wagner de Souza Fernandes, Natália Oliveira Alves, Aline Etelvina Casaril Arrua, Ana Isabel do Nascimento, Lisany Krug Mareto, Micael Viana de Azevedo, Camila Guadeluppe Maciel, Márcio José de Medeiros, Moreno Magalhães de Souza Rodrigues, Zilton Vasconcelos, Karin Nielsen-Saines, Rivaldo Venâncio da Cunha, Cláudia Du Bocage Santos-Pinto, and Everton Falcão de Oliveira. Early and long-term adverse outcomes of in utero zika exposure. Pediatrics, Jan 2025. URL: https://doi.org/10.1542/peds.2024-067552, doi:10.1542/peds.2024-067552. This article has 11 citations and is from a highest quality peer-reviewed journal.
(mccain2026asystematicreview pages 1-2): Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick Doohan, Keith Fraser, Anna-Maria Hartner, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Richard J. Sheppard, H. Juliette T. Unwin, Kelly Charniga, Zulma M. Cucunubá, Gina Cuomo-Dannenburg, Natsuko Imai-Eaton, Edward S. Knock, Adam Kucharski, Mantra Kusumgar, Paul Liétar, Rebecca K. Nash, Sabine van Elsland, Aaron Morris, Alpha Forna, Amy Dighe, Anna-Maria Hartner, Anne Cori, Arran Hamlet, Ben Lambert, Bethan Cracknell Daniels, Charles Whittaker, Cosmo Santoni, Cyril Geismar, Dariya Nikitin, David Jorgensen, Dominic P. Dee, Edward S. Knock, Hayley Thompson, Isobel Routledge, Jack Wardle, Janetta Skarp, Joseph Hicks, Kanchan Parchani, Kieran Drake, Lily Geidelberg, Lorenzo Cattarino, Mara Kont, Marc Baguelin, Pablo N. Perez-Guzman, Paula Christen, Rebecca Nash, Richard Fitzjohn, Richard Sheppard, Rob Johnson, Sabine van Elsland, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Sreejith Radhakrishnan, Tristan M. Naidoo, Zulma M. Cucunubá, Nuno R. Faria, Anne Cori, Ruth McCabe, and Ilaria Dorigatti. A systematic review and meta-analysis of zika virus epidemiology. Nature Health, 1:355-367, Feb 2026. URL: https://doi.org/10.1038/s44360-025-00051-4, doi:10.1038/s44360-025-00051-4. This article has 1 citations.
(shah2024analysisofcongenital pages 13-15): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.
(wong2025zikavirusand pages 2-3): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.
(martelli2024clinicalspectrumof pages 3-4): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.
(shah2024analysisofcongenital pages 10-12): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.
(shah2024analysisofcongenital pages 1-3): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.
(mccain2026asystematicreview pages 7-7): Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick Doohan, Keith Fraser, Anna-Maria Hartner, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Richard J. Sheppard, H. Juliette T. Unwin, Kelly Charniga, Zulma M. Cucunubá, Gina Cuomo-Dannenburg, Natsuko Imai-Eaton, Edward S. Knock, Adam Kucharski, Mantra Kusumgar, Paul Liétar, Rebecca K. Nash, Sabine van Elsland, Aaron Morris, Alpha Forna, Amy Dighe, Anna-Maria Hartner, Anne Cori, Arran Hamlet, Ben Lambert, Bethan Cracknell Daniels, Charles Whittaker, Cosmo Santoni, Cyril Geismar, Dariya Nikitin, David Jorgensen, Dominic P. Dee, Edward S. Knock, Hayley Thompson, Isobel Routledge, Jack Wardle, Janetta Skarp, Joseph Hicks, Kanchan Parchani, Kieran Drake, Lily Geidelberg, Lorenzo Cattarino, Mara Kont, Marc Baguelin, Pablo N. Perez-Guzman, Paula Christen, Rebecca Nash, Richard Fitzjohn, Richard Sheppard, Rob Johnson, Sabine van Elsland, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Sreejith Radhakrishnan, Tristan M. Naidoo, Zulma M. Cucunubá, Nuno R. Faria, Anne Cori, Ruth McCabe, and Ilaria Dorigatti. A systematic review and meta-analysis of zika virus epidemiology. Nature Health, 1:355-367, Feb 2026. URL: https://doi.org/10.1038/s44360-025-00051-4, doi:10.1038/s44360-025-00051-4. This article has 1 citations.
(rabe2025areviewof pages 1-2): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.
(rabe2025areviewof pages 3-4): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.
(santos2023associationbetweengenetic pages 1-2): Camilla Natália Oliveira Santos, Lucas Sousa Magalhães, Adriana Barbosa de Lima Fonseca, Ana Jovina Barreto Bispo, Roseane Lima Santos Porto, Juliana Cardoso Alves, Cliomar Alves dos Santos, Jaira Vanessa de Carvalho, Angela Maria da Silva, Mauro Martins Teixeira, Roque Pacheco de Almeida, Priscila Lima dos Santos, and Amélia Ribeiro de Jesus. Association between genetic variants in trem1, cxcl10, il4, cxcl8 and tlr7 genes with the occurrence of congenital zika syndrome and severe microcephaly. Scientific Reports, Mar 2023. URL: https://doi.org/10.1038/s41598-023-30342-3, doi:10.1038/s41598-023-30342-3. This article has 22 citations and is from a peer-reviewed journal.
(marques2025geneticmodifiersof pages 10-13): Fernanda J P Marques, Janet Ruan, Rozel B. Razal, Marcio Leyser, and Youssef A. Kousa. Genetic modifiers of prenatal brain injury after zika virus infection: a scoping review. medRxiv : the preprint server for health sciences, Jan 2025. URL: https://doi.org/10.1101/2025.01.02.25319896, doi:10.1101/2025.01.02.25319896. This article has 0 citations.
(santos2023associationbetweengenetic pages 4-5): Camilla Natália Oliveira Santos, Lucas Sousa Magalhães, Adriana Barbosa de Lima Fonseca, Ana Jovina Barreto Bispo, Roseane Lima Santos Porto, Juliana Cardoso Alves, Cliomar Alves dos Santos, Jaira Vanessa de Carvalho, Angela Maria da Silva, Mauro Martins Teixeira, Roque Pacheco de Almeida, Priscila Lima dos Santos, and Amélia Ribeiro de Jesus. Association between genetic variants in trem1, cxcl10, il4, cxcl8 and tlr7 genes with the occurrence of congenital zika syndrome and severe microcephaly. Scientific Reports, Mar 2023. URL: https://doi.org/10.1038/s41598-023-30342-3, doi:10.1038/s41598-023-30342-3. This article has 22 citations and is from a peer-reviewed journal.
(wong2025zikavirusand pages 1-2): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.
(metzler2024zikavirusneuropathogenesis—research pages 1-2): Anna D. Metzler and Hengli Tang. Zika virus neuropathogenesis—research and understanding. Pathogens, 13:555, Jul 2024. URL: https://doi.org/10.3390/pathogens13070555, doi:10.3390/pathogens13070555. This article has 23 citations.
(madere2025flavivirusinfectionsand pages 5-6): Ferralita S. Madere, Aurea Virginia Andrade da Silva, Efemena Okeze, Emma Tilley, Andriyan Grinev, Krishnamurthy Konduru, Mayra García, and Maria Rios. Flavivirus infections and diagnostic challenges for dengue, west nile and zika viruses. npj Viruses, Apr 2025. URL: https://doi.org/10.1038/s44298-025-00114-z, doi:10.1038/s44298-025-00114-z. This article has 43 citations.
(madere2025flavivirusinfectionsand pages 1-2): Ferralita S. Madere, Aurea Virginia Andrade da Silva, Efemena Okeze, Emma Tilley, Andriyan Grinev, Krishnamurthy Konduru, Mayra García, and Maria Rios. Flavivirus infections and diagnostic challenges for dengue, west nile and zika viruses. npj Viruses, Apr 2025. URL: https://doi.org/10.1038/s44298-025-00114-z, doi:10.1038/s44298-025-00114-z. This article has 43 citations.
(max2024neurodevelopmentinpreschool pages 1-3): Ryan Max, Christian Toval-Ruiz, Sylvia Becker-Dreps, Anna M Gajewski, Evelin Martinez, Kaitlyn Cross, Bryan Blette, Oscar Ortega, Damaris Collado, Omar Zepeda, Itziar Familiar, Michael J Boivin, Meylin Chavarria, María José Meléndez, Juan Carlos Mercado, Aravinda de Silva, Matthew H Collins, Daniel Westreich, Sandra Bos, Eva Harris, Angel Balmaseda, Emily W Gower, Natalie M Bowman, Elizabeth Stringer, and Filemón Bucardo. Neurodevelopment in preschool children exposed and unexposed to zika virus in utero in nicaragua: a prospective cohort study. The Lancet. Global health, 12:e1129-e1138, Jul 2024. URL: https://doi.org/10.1016/s2214-109x(24)00176-1, doi:10.1016/s2214-109x(24)00176-1. This article has 7 citations.
(gardinali2025congenitalzikavirus pages 3-4): Noemi Rovaris Gardinali, Renato Sergio Marchevsky, Yara Cavalcante Vieira, Marcelo Pelajo-Machado, Tatiana Kugelmeier, Juliana Gil Melgaço, Márcio Pinto Castro, Jaqueline Mendes de Oliveira, and Marcelo Alves Pinto. Congenital zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface. Memórias do Instituto Oswaldo Cruz, Feb 2025. URL: https://doi.org/10.1590/0074-02760240125, doi:10.1590/0074-02760240125. This article has 1 citations.
(NCT04917861 chunk 1): A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas. ModernaTX, Inc.. 2021. ClinicalTrials.gov Identifier: NCT04917861
(NCT03110770 chunk 1): VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents. National Institute of Allergy and Infectious Diseases (NIAID). 2017. ClinicalTrials.gov Identifier: NCT03110770
(NCT06334393 chunk 1): Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults. Valneva Austria GmbH. 2024. ClinicalTrials.gov Identifier: NCT06334393
(metzler2024zikavirusneuropathogenesis—research pages 13-14): Anna D. Metzler and Hengli Tang. Zika virus neuropathogenesis—research and understanding. Pathogens, 13:555, Jul 2024. URL: https://doi.org/10.3390/pathogens13070555, doi:10.3390/pathogens13070555. This article has 23 citations.
(horvath2025ahumanizedmouse pages 1-5): Allison R. Horvath, Clara M. Abdelmalek, Eunbin Park, Aubrey P. Alexander, Sadhana A. Maheswaran, Arnav H. Patel, Nandi G. Patel, Janet E. Ruan, Ademide T. Adeyemo, Erin C. Li, Katherine E. Helmicki, Stephen Lin, Paul C. Wang, Zhen Li, Li Wang, Heather A. Gordish-Dressman, Tarik F. Haydar, Tamer A. Mansour, and Youssef A. Kousa. A humanized mouse model system mimics prenatal zika infection and reveals premature differentiation of neural stem cells. bioRxiv, Feb 2025. URL: https://doi.org/10.1101/2025.02.21.639556, doi:10.1101/2025.02.21.639556. This article has 2 citations.
(gardinali2025congenitalzikavirus pages 2-3): Noemi Rovaris Gardinali, Renato Sergio Marchevsky, Yara Cavalcante Vieira, Marcelo Pelajo-Machado, Tatiana Kugelmeier, Juliana Gil Melgaço, Márcio Pinto Castro, Jaqueline Mendes de Oliveira, and Marcelo Alves Pinto. Congenital zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface. Memórias do Instituto Oswaldo Cruz, Feb 2025. URL: https://doi.org/10.1590/0074-02760240125, doi:10.1590/0074-02760240125. This article has 1 citations.